Mah Sing gets clearances to market medical gloves in US market

KUALA LUMPUR: Mah Sing Group Bhd's healthcare business unit, Mah Sing Healthcare Sdn Bhd, is poised to market medical-grade examination gloves in the United States after obtaining premarket notification clearances from the United States (US) Food and Drug Administration (FDA).

The property developer, which diversified into glove manufacturing this year, said the subsidiary had received the US FDA’s notification letter dated Dec 4, 2021, on the 510(k) premarket notification clearances to market nitrile examination gloves.